FDA green lights Bizengri drug to treat rare, aggressive bile duct cancer
The U.S. Food and Drug Administration (FDA) has approved Bizengri to treat an ultra-rare, aggressive cancer that forms in the bile ducts.
May 11, 2026
0
4
Respiratory Tract Diseases: News and Research on Respiratory Tract Neoplasms
MeSH tree: C08.785
Researchers find biomarker of chemotherapy resistance in relapsed lung cancer
Researchers from The University of Texas MD Anderson Cancer Center have discovered that some cancer cells express the YAP1 protein only after treatment with chemotherapy, allowing them to survive by becoming more invasive ...
May 6, 2026
0
5
Experimental KRAS G12D drug slows cancer growth, shrinks tumors in early test
A first-in-human clinical trial led by an international team of researchers and published in the New England Journal of Medicine found that setidegrasib, an investigational targeted therapy drug designed to eliminate a key ...
May 2, 2026
0
23
Tunnel workers report being exposed to significant silica dust risks
The responses to a national survey have revealed tunnel construction workers across Australia say they face significant exposure to silica dust, a hazardous dust that can cause incurable diseases like silicosis and lung cancer.
Apr 30, 2026
0
3
FDA moves to real-time clinical trial patient monitoring, faster drug review
The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials.
Apr 29, 2026
0
5
Age, sex, and cancer type can influence risk of subsequent cancers among survivors
The risk of developing a subsequent primary cancer varied significantly by age at initial diagnosis, sex, and type of first cancer, according to a study by Oxana Palesh and Susan Hong and colleagues at Virginia Commonwealth ...
Apr 28, 2026
0
11
Battery-free airway device could spot stent complications early through remote monitoring
Vanderbilt researchers led by Xiaoguang Dong, assistant professor of mechanical engineering, have developed a novel device that can be used remotely to continuously monitor the airway stents of patients with diseases like ...
Apr 27, 2026
0
6
Next-generation KRAS G12C inhibitor elisrasib elicited promising response rates in patients with advanced lung cancer
Treatment with the investigational next-generation KRAS-G12C inhibitor elisrasib led to clinical benefit in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors harbored a KRAS G12C ...
Apr 25, 2026
0
10
MorphoGenie learns reusable cell features that could sharpen disease diagnosis
Cells contain a wealth of information about health and disease, but extracting that data reliably from microscope images remains a major challenge. Many important differences between healthy and diseased cells are too subtle ...
Apr 22, 2026
0
3
Asphalt is everywhere, but is it bad for our health?
If you piled all of Phoenix's pavement into one spot, it would be enough to cover San Francisco four times over. Roads, parking lots, and other paved surfaces blanket a lot of land—an estimated 40% of Arizona's capital city.
Apr 22, 2026
0
14
